| BEV | bevacizumab |
| CDR | Crohn’s disease-like response |
| CRCLM | colorectal cancer liver metastasis |
| CRS | cancer risk score |
| DFS | disease free survival |
| HA | hyaluronic acid |
| HGP | histopathologic growth patterns |
| dHGP | desmoplastic histopathologic growth patterns |
| rHGP | replacement histopathologic growth patterns |
| IHC | immunohistochemistry |
| LM | liver metastasis |
| LR | liver resection |
| MSI | microsatellite instability |
| MVD | microvascular density |
| OS | overall survival |
| PFS | progression free survival |
| RFS | recurrence free survival |
| TBS | tumor budding score |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.